LABORATORIOS FARMACEUT./ ES0157261019 /
14/05/2024 14:31:11 | Var. +0.20 | Volume | Denaro14:31:11 | Lettera14:31:11 | Max | Min |
---|---|---|---|---|---|---|
84.65EUR | +0.24% | - Fatturato: - |
84.65Quantità in denaro: - | 84.90Quantità in lettera: - | 85.50 | 84.40 |
GlobeNewswire
14:22
Leading Law Firm Bleichmar Fonti & Auld LLP announces an investigation of WideOpenWest, Inc.’s (NYSE...
GlobeNewswire
14:15
Newton Golf Shafts Helps Propel Doug Barron to His First Major Championship on the PGA TOUR Champion...
GlobeNewswire
14:15
Gratus Capital Partners with iCapital® to Launch Hedge Fund Investing Opportunities to Wealth Manage...
GlobeNewswire
14:15
STRATA Skin Sciences Surpasses 100 Domestic Installations of TheraClear®X Devices as of March 31, 20...
Newsfile Corp
14:11
Federation of Shenzhen Industries: 36 Shenzhen Brands Listed In "Brand Finance China 500 2024"
GlobeNewswire
14:10
American Oncology Network Announces Date Change for First Quarter 2024 Earnings Release Date and Con...
GlobeNewswire
14:07
DRFortress Expands Cloud Connectivity Capabilities for Hawaii Businesses with Megaport Cloud Connect
GlobeNewswire
14:06
Sysco Celebrates Arrival of Heavy-Duty Electric Vehicles in Its Headquarters City of Houston, TX, Gr...
GlobeNewswire
14:05
Palisade Bio Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
14:00
Jasper Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Developments
GlobeNewswire
14:00
Franklin Electric Appoints Joe Ruzynski as CEO; Gregg Sengstack Remains Executive Chairperson
GlobeNewswire
14:00
Optimi Health Receives Certificate of Analysis For MDMA 40mg and 60mg GMP Capsules
GlobeNewswire
14:00
Provectus Biopharmaceuticals Announces Eight Presentations of Rose Bengal Photodynamic Antimicrobial...
GlobeNewswire
14:00
Tenax Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update
GlobeNewswire
14:00
Daré Bioscience Reports First Quarter 2024 Financial Results and Provides Company Update
GlobeNewswire
14:00
Ovid Therapeutics Reports Business Updates and First Quarter 2024 Financial Results